Krebiozen

From WikiMD.org
Jump to navigation Jump to search

Krebiozen

Krebiozen (pronounced: kreb-ee-OH-zen) is a controversial and largely discredited cancer treatment that was popular in the United States during the mid-20th century.

Etymology

The term "Krebiozen" is derived from the name of the scientist who purportedly discovered it, Dr. Andrew C. Ivy, and the Greek word "bios," meaning life. The "zen" suffix was added to suggest a sense of calm or peace.

Definition

Krebiozen is a substance that was claimed to be a cure for cancer in the 1950s and 1960s. It was introduced by Dr. Andrew C. Ivy, a prominent physiologist at the University of Illinois. Despite initial enthusiasm, subsequent research failed to confirm its efficacy, and it is now considered a discredited treatment.

History

Krebiozen was first introduced in 1951 by Dr. Andrew C. Ivy. He claimed that the substance, which was derived from horse serum, had remarkable cancer-fighting properties. However, independent studies conducted by the American Medical Association and the Food and Drug Administration failed to replicate his results. Despite this, Krebiozen remained popular among some segments of the public until the 1970s.

Controversy

The Krebiozen controversy is a significant event in the history of medical ethics. It raised important questions about the role of scientific evidence in medical practice, the influence of public opinion on health policy, and the potential for exploitation in the promotion of unproven treatments.

Related Terms

  • Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.
  • Placebo: A substance that has no therapeutic effect, used as a control in testing new drugs.
  • Quackery: The promotion of fraudulent or ignorant medical practices.

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski